Liver cirrhosis : causes, diagnosis, and treatment / Miranda L. Michelli, editor.

Format:

Book

Contributor:

Michelli, Miranda L.

Series:

Hepatology Research and Clinical Developments

Hepatology research and clinical developments

Language:

English

Subjects (All):

Liver--Cirrhosis.

Liver.

Liver--Diseases.

Physical Description:

1 online resource (304 p.)

Edition:

1st ed.

Place of Publication:

New York : Nova Biomedical Books, c2011.

Language Note:

English

Summary:

Topical research in the study of liver cirrhosis, including etiologic types of end stage chronic liver disease; hepatocellular carcinoma screening in the cirrhotic patient; hepatic myofibroblasts and their role in liver fibrogenesis; the role of trace elements in the pathogenesis of liver cirrhosis and cell-based therapy for liver cirrhosis.

Contents:

""LIVER CIRRHOSIS: CAUSES, DIAGNOSIS AND TREATMENT ""; ""LIVER CIRRHOSIS: CAUSES, DIAGNOSIS AND TREATMENT ""; ""Contents ""; ""Preface ""; ""Thalidomide and its Analogs: A Potential Immunomodulatory Alternative for Treating Liver Diseases and Cirrhosis ""; ""Abstract ""; ""Introduction""; ""History of Thalidomide ""; ""Thalidomide Chemical Properties ""; ""Thalidomide and its Analogs: Characteristics and Mechanisms of Action ""; ""Thalidomide and its Analogs: Pharmacokinetics and Metabolism ""; ""Current Uses for Thalidomide and Some Analogs""; ""Cytokines and Liver Damage ""

""Immunomodulation on Cytokines: Restoring the Proinflammatory and Antiinflammatory Disequilibrium""""Cytokines Role in Deleterious Processes of Liver Damage ""; ""Thalidomide Effects on Liver Damage and Cirrhosis ""; ""Thalidomide Effects on Liver Damage ""; ""Thalidomide Effects on Fibrosis, Cirrhosis and its Complications ""; ""Thalidomide in Experimental and Clinical Hepatocellular Carcinoma (HCC)""; ""Adverse Effects by Thalidomide: Hepatotoxicity ""; ""Conclusion ""; ""References ""; ""Role of the Energy State of Liver Cell in Cirrhosis Development and Treatment ""; ""Abstract ""

""Introduction""""Hepatic Circulation ""; ""Liver Composition ""; ""Liver Metabolism""; ""Energy Supply in the Liver ""; ""Control of Energy Metabolism ""; ""Cell Redox State in the Liver ""; ""Intracellular Calcium Dynamics in the Liver Relationship with Energy Necessities ""; ""Physiopathology of Cirrhosis""; ""Energy Metabolism in Hepatotoxicity ""; ""Collagen Metabolism and Cell Redox State ""; ""Oxidative Stress and Proliferative Potential in Experimental Cirrhosis ""; ""Energy Metabolism in Patients with Liver Damage ""

""Reversion of Preestablished CCl4-Induced Micronodular Cirrhosis""""Adenosine and its Derivates ""; ""Antifibrotic Therapy ""; ""Conclusion ""; ""Acknowledgments ""; ""References ""; ""End Stage Chronic Liver Disease � Yesterday, Today and Tomorrow ""; ""Abstract ""; ""Introduction ""; ""Etiologic Types of Cirrhosis and Other End Stage CLD""; ""1. Alcohol Related Cirrhosis/End Stage CLD ""; ""1.1. Evolution of Knowledge ""; ""1.2. Identification of Alcohol as Etiology ""; ""1.3. Prevalence and Temporal Changes""; ""2. Hepatitis B Virus Related Cirrhosis/End Stage CLD""

""2.1. Evolution of Knowledge """"2.2. Identification of HBV as Etiology ""; ""2.3. Prevalence and Temporal Changes ""; ""3. Hepatitis C Virus Related Cirrhosis/End Stage CLD ""; ""3.1. Evolution of Knowledge ""; ""3.2. Identification of HCV as Etiology ""; ""3.3. Prevalence and Temporal Changes ""; ""4. NAFLD Related Cirrhosis/End Stage CLD ""; ""4.1. Evolution of Knowledge ""; ""4.2. Identification of NAFLD as Etiology""; ""4. 3. Prevalence and Temporal Changes ""; ""5. Multiple Etiology Related Cirrhosis/End Stage CLD ""; ""6. Cryptogenic (of Unknown Etiology) Cirrhosis/End Stage CLD ""

""7. Noncirrhotic Portal Fibrosis (NCPF) Related End Stage CLD""

Notes:

Description based upon print version of record.

Includes bibliographical references and index.

Description based on print version record.

ISBN:

1-61942-156-9

OCLC:

923653842